Roca-Tey Ramon, Arcos Emma, Comas Jordi, Cao Higini, Tort Jaume
Coordinator of the vascular accesses working group of the Catalan Society of Nephrology (SCN), Barcelona - Spain.
Department of Nephrology, Hospital de Mollet, Barcelona - Spain.
J Vasc Access. 2015 Nov-Dec;16(6):472-9. doi: 10.5301/jva.5000410. Epub 2015 Jun 15.
Arteriovenous fístula is the best vascular access (VA) for hemodialysis. We analyzed the VA used at first session and the factors associated with the likelihood to start hemodialysis by fistula in 2000-2011.
Data of VA type were obtained in 9,956 incident hemodialysis patients from the Catalan Registry.
Overall, 47.9% of patients initiated hemodialysis with a fistula, 1.2% with a graft, 15.9% with a tunneled catheter and 35% with an untunneled catheter. The percentage of incident patients with fistula and catheter has remained stable at around 50% over the years. The likelihood to start hemodialysis with fistula was significantly lower in females [adjusted odds ratio: 0.69, 95% confidence interval (CI): 0.61-0.75], patients aged 18-44 years (0.78, 95% CI: 0.64-0.94), patients with comorbidity (0.67, 95% CI: 0.60-0.75) and tended to be lower in patients aged over 74 years (0.89, 95% CI: 0.78-1.01). The probability to use fistula was significantly higher in patients with polycystic kidney disease (2.08, 95% CI: 1.63-2.67), predialysis nephrology care longer than 2 years (4.14, 95% CI: 3.63-4.73) and steady chronic kidney disease (CKD) progression (10.97, 95% CI: 8.41-14.32). During 1 year of follow-up, 67.2% and 59.6% of patients using untunneled and tunneled catheter changed to fistula, respectively.
Starting hemodialysis by fistula was related with nonmodifiable patient characteristics and modifiable CKD practice processes, such as predialysis care duration. Half of the incident patients were exposed annually in Catalonia to potential catheter complications. This scenario can be improved by optimizing the processes of CKD care.
动静脉内瘘是血液透析的最佳血管通路(VA)。我们分析了2000年至2011年首次透析时使用的血管通路以及与通过内瘘开始血液透析可能性相关的因素。
从加泰罗尼亚登记处获取了9956例新接受血液透析患者的血管通路类型数据。
总体而言,47.9%的患者以动静脉内瘘开始血液透析,1.2%使用移植血管,15.9%使用带隧道的导管,35%使用无隧道的导管。多年来,新发病例中使用内瘘和导管的患者比例一直稳定在50%左右。女性患者[调整后的优势比:0.69,95%置信区间(CI):0.61 - 0.75]、18 - 44岁的患者(0.78,95% CI:0.64 - 0.94)、患有合并症的患者(0.67,95% CI:0.60 - 0.75)通过动静脉内瘘开始血液透析的可能性显著较低,74岁以上的患者也有降低趋势(0.89,95% CI:0.78 - 1.01)。多囊肾病患者(2.08,95% CI:1.63 - 2.67)、透析前肾病护理时间超过2年的患者(4.14,95% CI:3.63 - 4.73)以及慢性肾脏病(CKD)稳定进展的患者(10.97,95% CI:8.41 - 14.32)使用内瘘的概率显著更高。在1年的随访期间,分别有67.2%和59.6%使用无隧道导管和带隧道导管的患者改为使用内瘘。
通过动静脉内瘘开始血液透析与不可改变的患者特征以及可改变的CKD诊疗过程有关,如透析前护理时间。在加泰罗尼亚,每年有一半的新发病例面临潜在的导管并发症风险。通过优化CKD护理流程可以改善这种情况。